IRCT20190523043674N1已完成1 期
Fecal microbiota transplantation (FMT) for treatment of polycystic ovary syndrome: a clinical trial phase I
Boushehr University of Medical Sciences0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 35 years（—）
- 性别
- Female
入选标准
- •Adult women 15-35
- •Currently diagnosed PCOS patient without treatment
- •PCOS patient with long time treatment
- •According to Rotterdam criteria patient must have menstural irregularity, hyperandrogenism and PCOS ultrasonography indices and must not have other diseases (at least two criteria)
- •More than 1 month menstural irregularity
- •More than 3 months secondary amenorrhea
- •Hyperandrogenism signs including acnea and hirsutism
- •Hyperandrogenemia (total testosterone of serum >0/5 ng/mL)
- •Non-smoker, without any addiction and non-alcohol consumer patients
- •Obese patient (BMI>20)
- •Abnormal uterine bleeding
排除标准
- •Any GI disorders
- •Immuno-compromised patients or usage of immuno-suppressant drugs
- •Improving of PCO symptoms after treatment with drugs
- •Food Allergy
- •Chronic diarrhea
- •Antibiotic intake 3 days before transplantation
- •Any history of cancer
- •Congenital diseases such as adrenal hyperplesia
- •Cushing's disease
- •Acromegaly & Gigantism
- •Type 1& 2 Diabetes
研究者
相似试验
招募中
不适用
The efficacy and safety of faecal microbiota transplantation for recurrent or relapsing Clostridium difficile in Western AustraliaACTRN12615001220550Fiona Stanley Fremantle Hospital Group50
尚未招募
2 期
Stool transplant for treatment of colitis and crohns diseaseCTRI/2021/03/032131Dayanand Medical College and Hospital
尚未招募
3 期
Fecal Therapy for ColitisCTRI/2021/03/032332Dayanand Medical College and Hospital
招募中
2 期
A-FMT for active UCMild to moderate ulcerative colitisUlcerative colitisJPRN-jRCTs031220542agahara Akihito37
招募中
2 期
Efficacy of Fecal Microbiota Transplantation (FMT) in Irritable Bowel Syndrome (IBS): A Randomized, placebo-controlled, double-blind studyirritable bowel syndromefecal microbiota transplantationtreatment outcomequality of lifeTCTR20230904002Thammasat university45